Literature DB >> 30287058

One-year clinical outcomes in older patients with non-ST elevation acute coronary syndrome undergoing coronary angiography: An analysis of the ICON1 study.

Jonathan Batty1, Weiliang Qiu2, Sophie Gu1, Hannah Sinclair3, Murugapathy Veerasamy3, Benjamin Beska1, Dermot Neely4, Gary Ford5, Vijay Kunadian6.   

Abstract

AIMS: The aim of this prospective, observational study was to identify predictors of adverse outcome at one year, following invasive care of older patients with non-ST-elevation acute coronary syndrome (NSTEACS) according to frailty status.
METHODS: Older patients (aged ≥ 75 years), presenting with NSTEACS, undergoing invasive coronary angiography with a view to revascularisation, underwent assessment of frailty, cognition, functional status and quality of life. Participants were categorised as robust, pre-frail or frail using the Fried criteria. The primary outcome comprised a composite of all-cause mortality, myocardial infarction, stroke, unplanned revascularisation and major bleeding, at one year. Cox proportional hazards regression was used to derive a multivariate risk score.
RESULTS: Overall, the composite endpoint was observed in 81 participants (29%). There was a significant difference in the occurrence of the primary outcome in the 3 frailty groups (robust 18.0%, pre-frail 27.5% and frail 39%; p = 0.03; hazard ratio (HR) for frail vs. robust: 2.79, 95% Confidence Interval [CI] 1.28-6.08). Fried frailty classification, age (categorised as ≥85 years), raised Killip class, systolic blood pressure on admission, history of peripheral vascular disease (PVD), problems dressing self and implantation of a bare metal stent were identified as predictors of adverse events at one year, with a C-statistic of 0.77 (95% CI 0.71-0.83). A point-based clinical risk score (FRAIL-HEART) was defined, which had a C-statistic of 0.70 (95% CI 0.63-0.77) and significantly outperformed the GRACE 2 score.
CONCLUSION: Frailty is associated with adverse clinical outcomes, following invasive management of older patients with NSTEACS. The derived risk models may enable improved risk stratification in practice.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Ageing; Frailty; Individualised decision-making; NSTEACS; Risk stratification

Mesh:

Year:  2018        PMID: 30287058     DOI: 10.1016/j.ijcard.2018.09.086

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  10 in total

1.  Five-year clinical outcomes in patients with frailty aged ≥75 years with non-ST elevation acute coronary syndrome undergoing invasive management.

Authors:  Hanna Ratcovich; Benjamin Beska; Greg Mills; Lene Holmvang; Jennifer Adams-Hall; Hannah Stevenson; Murugapathy Veerasamy; Chris Wilkinson; Vijay Kunadian
Journal:  Eur Heart J Open       Date:  2022-05-16

2.  Comparison of the prognostic value of frailty assessment tools in patients aged ≥ 65 years hospitalized in a cardiac care unit with acute coronary syndrome.

Authors:  Wojciech Nowak; Ilona Kowalik; Małgorzata Kuzin; Agnieszka Krauze; Anna Mierzyńska; Ewa Sadowy; Kamil Marcinkiewicz; Janina Stępińska
Journal:  J Geriatr Cardiol       Date:  2022-05-28       Impact factor: 3.189

3.  Is the contemporary care of the older persons with acute coronary syndrome evidence-based?

Authors:  Greg B Mills; Hanna Ratcovich; Jennifer Adams-Hall; Benjamin Beska; Emma Kirkup; Daniell E Raharjo; Murugapathy Veerasamy; Chris Wilkinson; Vijay Kunadian
Journal:  Eur Heart J Open       Date:  2021-12-17

4.  The association between vitamin D status and clinical events in high-risk older patients with non-ST elevation acute coronary syndrome undergoing invasive management.

Authors:  Benjamin Beska; Danny Chan; Sophie Gu; Weiliang Qiu; Helen Mossop; Dermot Neely; Vijay Kunadian
Journal:  PLoS One       Date:  2019-06-12       Impact factor: 3.240

5.  Cognitive Decline in Older Patients With Non- ST Elevation Acute Coronary Syndrome.

Authors:  Sophie Z Gu; Benjamin Beska; Danny Chan; Dermot Neely; Jonathan A Batty; Jennifer Adams-Hall; Helen Mossop; Weiliang Qiu; Vijay Kunadian
Journal:  J Am Heart Assoc       Date:  2019-02-19       Impact factor: 5.501

6.  The association of telomere length and telomerase activity with adverse outcomes in older patients with non-ST-elevation acute coronary syndrome.

Authors:  Danny Chan; Carmen Martin-Ruiz; Gabriele Saretzki; Dermot Neely; Weiliang Qiu; Vijay Kunadian
Journal:  PLoS One       Date:  2020-01-10       Impact factor: 3.240

Review 7.  Frailty Scores and Their Utility in Older Patients with Cardiovascular Disease.

Authors:  Kenneth Jordan Ng Cheong Chung; Chris Wilkinson; Murugapathy Veerasamy; Vijay Kunadian
Journal:  Interv Cardiol       Date:  2021-03-31

8.  Clinical Frailty Scale classes are independently associated with 6-month mortality for patients after acute myocardial infarction.

Authors:  Niklas Ekerstad; Dariush Javadzadeh; Karen P Alexander; Olle Bergström; Lars Eurenius; Mats Fredrikson; Gudny Gudnadottir; Claes Held; Karin Hellström Ängerud; Radwan Jahjah; Tomas Jernberg; Ewa Mattsson; Kjell Melander; Linda Mellbin; Monica Ohlsson; Annica Ravn-Fischer; Lars Svennberg; Troels Yndigegn; Joakim Alfredsson
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2022-02-08

9.  Impact of multimorbidity on long-term outcomes in older adults with non-ST elevation acute coronary syndrome in the North East of England: a multi-centre cohort study of patients undergoing invasive care.

Authors:  Benjamin Beska; Greg B Mills; Hanna Ratcovich; Chris Wilkinson; Abdulla A Damluji; Vijay Kunadian
Journal:  BMJ Open       Date:  2022-07-26       Impact factor: 3.006

10.  Association of frailty with all-cause mortality and bleeding among elderly patients with acute myocardial infarction: a systematic review and meta-analysis.

Authors:  Prapaipan Putthapiban; Wasawat Vutthikraivit; Pattara Rattanawong; Weera Sukhumthammarat; Napatt Kanjanahattakij; Jakrin Kewcharoen; Aman Amanullah
Journal:  J Geriatr Cardiol       Date:  2020-05       Impact factor: 3.327

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.